Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA

Abstract

Although caspase activation is generally thought to be necessary to induce apoptosis, recent evidence suggests that apoptosis can be activated in the setting of caspase inhibition. In this study, we tested the hypothesis that caspase-independent apoptotic pathways contribute to the development of heart failure in the absence of caspase activation. Acute cardiomyopathy was induced using a single dose of doxorubicin (Dox, 20 mg/kg) injected into male wild-type (WT) and transgenic (Tg) mice with a cardiac-specific expression of cytokine response modifier A (CrmA), a known caspase inhibitor. Early (6 day) survival was significantly better in CrmA Tg (81%) than WT (38%) mice. Twelve days after Dox injection, however, the mortality benefit had dissipated, and increased cardiac apoptosis was observed in both groups. There was, however, a significantly greater release of apoptosis-inducing factor (AIF) from mitochondria to cytosol in CrmA Tg compared with WT mice, which suggests that an enhancement of activation in caspase-independent apoptotic pathways had occurred. The administration of a poly(ADP-ribose) polymerase-1 inhibitor, 4-amino-1,8-naphthalimide (4-AN), to Dox-treated mice resulted in significantly improved cardiac function, a significant blockade of AIF released from mitochondria, and decreased cardiac apoptosis. There were also significantly improved survival in WT (18% without 4-AN vs. 89% with 4-AN) and CrmA Tg (13% without 4-AN vs. 93% with 4-AN) mice 12 days after Dox injection. In conclusion, these findings suggest that apoptosis can be induced in the heart lacking caspase activation via caspase-independent pathways and that enabling the inhibition of AIF activation may provide a significant cardiac benefit.

Doxorubicin-induced chronic dilated cardiomyopathy—the apoptosis hypothesis revisited

“…We further note that other proteases [27,28], metabolic dysfunction or autophagocytic processes [13] may also play a role in regulating cardiomyocyte demise, specifically when canonical caspase activation is blocked or initial injury is too severe [15].…”

Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction

“…Cardiac function was evaluated by measuring the left ventricular (LV) pressure-volume (PV) loop to calculate hemodynamic parameters, including cardiac output (CO), stroke work (SW), stroke volume (SV), and isovolumetric relaxation as described previously (3,13).…”

New Targets to Treat the Structural Remodeling of the Myocardium

“…Whereas some studies have shown that direct caspase inhibition reduces the acute loss of myocardium in various animal models, other studies indicate that caspase inhibition might not be able to completely inhibit apoptosis, likely because apoptosis can be induced in the ischemic-hypoxic injured heart lacking caspase activation by caspaseindependent pathways (63). Nevertheless, regarding alternative potential antiapoptotic therapies indirectly related to caspase inhibition for which some proof of principle exists, it is worth considering that UCF-101 (a small-molecule inhibitor of the mitochondrial Omi/HtrA2 serine protease released into the cytoplasm during induction of apoptosis, that in turn promotes caspase activation) rescues cardiomyocytes and restores LV dysfunction after ischemia/reperfusion injury in the rat heart (64).…”